Schedule 13G ownership disclosure

APTEVO THERAPEUTICS INC

Security class unavailable · CUSIP: 03835L306

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
935,552
Percent of class
6.9600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002033916-24-000031
Form type
SC 13G
Filer
Aptevo Therapeutics Inc.
CIK
CIK 1671584
Filed
Nov 08, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub